Evidence map›Paper›PMID 37460794›Full record

ArticleNature nanotechnology2023

DNA-origami-directed virus capsid polymorphism.

Iris Seitz, Sharon Saarinen, Esa-Pekka Kumpula, Donna McNeale, Eduardo Anaya-Plaza, Vili Lampinen, Vesa P Hytönen, Frank Sainsbury, Jeroen J L M Cornelissen, Veikko Linko and 2 more

Abstract read
In one paragraph

Article in Nature nanotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Design Considerations for Potent DNA-Platform-Based Cancer Vaccines.Current opinion in biomedical engineering · 2026
    Article
  3. Article
  4. Review
  5. Design andMaterials today. Bio · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Radiation and DNA Origami Nanotechnology: Probing Structural Integrity at the Nanoscale.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025
    Review
  17. Raman Imaging of Targeted Drug Delivery with DNA-Based Nano-Optical Devices.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  18. Bottom-up synthetic immunology.Nature nanotechnology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Iris SeitzDepartment of Bioproducts and Biosystems, Aalto University, Aalto, Finland.ORCID http://orcid.org/0000-0001-6552-9894
Sharon SaarinenDepartment of Bioproducts and Biosystems, Aalto University, Aalto, Finland.
Esa-Pekka KumpulaInstitute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-0335-5993
Donna McNealeCentre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia.ORCID http://orcid.org/0000-0002-3342-3216
Eduardo Anaya-PlazaDepartment of Bioproducts and Biosystems, Aalto University, Aalto, Finland.
Vili LampinenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID http://orcid.org/0000-0003-2153-6149
Vesa P HytönenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Frank SainsburyCentre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia.ORCID http://orcid.org/0000-0001-8152-3820
Jeroen J L M CornelissenDepartment of Molecules and Materials, MESA+ Institute for Nanotechnology, University of Twente, Enschede, Netherlands.ORCID http://orcid.org/0000-0002-9728-5043
Veikko LinkoDepartment of Bioproducts and Biosystems, Aalto University, Aalto, Finland.ORCID http://orcid.org/0000-0003-2762-1555
Juha T HuiskonenInstitute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland. juha.huiskonen@helsinki.fi.ORCID http://orcid.org/0000-0002-0348-7323
Mauri A KostiainenDepartment of Bioproducts and Biosystems, Aalto University, Aalto, Finland. mauri.kostiainen@aalto.fi.ORCID http://orcid.org/0000-0002-8282-2379

Funding

European Research Council 101002258European Research Council 85670
6 · The paper itself

Abstract

Viral capsids can adopt various geometries, most iconically characterized by icosahedral or helical symmetries. Importantly, precise control over the size and shape of virus capsids would have advantages in the development of new vaccines and delivery systems. However, current tools to direct the assembly process in a programmable manner are exceedingly elusive. Here we introduce a modular approach by demonstrating DNA-origami-directed polymorphism of single-protein subunit capsids. We achieve control over the capsid shape, size and topology by employing user-defined DNA origami nanostructures as binding and assembly platforms, which are efficiently encapsulated within the capsid. Furthermore, the obtained viral capsid coatings can shield the encapsulated DNA origami from degradation. Our approach is, moreover, not limited to a single type of capsomers and can also be applied to RNA-DNA origami structures to pave way for next-generation cargo protection and targeting strategies.

Indexed as

CapsidNanostructuresCapsid ProteinsDNAVirionCapsid ProteinsDNA

Identifiers

PMID37460794
PMCPMC10575778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.